Literature DB >> 12359649

Occupational airborne exposure and the incidence of respiratory symptoms and asthma.

Tomas M L Eagan1, Amund Gulsvik, Geir E Eide, Per S Bakke.   

Abstract

Several prevalence studies have suggested an association between occupational exposure and respiratory symptoms and asthma, but there has been a lack of incidence studies to verify this. This study examined the incidence of respiratory symptoms and asthma in an 11-year Norwegian community cohort study with 2,819 subjects. Predictors examined were sex, age, educational level, lifetime exposure to quartz, asbestos, and dust or fumes, as well as smoking habits and pack-years. The prevalence of exposure to quartz, asbestos, and dust or fumes was, respectively, 3.7%, 5.0%, and 28.3% at baseline. In those exposed to dust or fumes, the odds ratios (95% confidence intervals) varied between 1.4 (1.1, 1.7) and 2.1 (1.3, 3.2) for developing respiratory symptoms or asthma after adjusting for sex, age, educational level, and smoking. Between 5.7% and 19.3% of the incidence of respiratory symptoms and 14.4% of the incidence of asthma were attributable to dust or fumes exposure after adjustment for sex, age, educational level, and smoking. In conclusion, airborne occupational exposure increases the incidence of respiratory symptoms and asthma, independent of sex, age, educational level, smoking habits, and pack-years.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359649     DOI: 10.1164/rccm.200203-238OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  22 in total

1.  Desert dust exposure is associated with increased risk of asthma hospitalization in children.

Authors:  Kumiko T Kanatani; Isao Ito; Wael K Al-Delaimy; Yuichi Adachi; William C Mathews; Joe W Ramsdell
Journal:  Am J Respir Crit Care Med       Date:  2010-07-23       Impact factor: 21.405

2.  Indoor exposures and respiratory symptoms in a Norwegian community sample.

Authors:  T Duelien Skorge; T M L Eagan; G E Eide; A Gulsvik; P S Bakke
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

3.  Indoor particle counts during Asian dust events under everyday conditions at an apartment in Japan.

Authors:  Kumiko T Kanatani; Motonori Okumura; Susumu Tohno; Yuichi Adachi; Keiko Sato; Takeo Nakayama
Journal:  Environ Health Prev Med       Date:  2013-08-10       Impact factor: 3.674

Review 4.  Asthma: epidemiology, etiology and risk factors.

Authors:  Padmaja Subbarao; Piush J Mandhane; Malcolm R Sears
Journal:  CMAJ       Date:  2009-09-14       Impact factor: 8.262

5.  Non-sensitising air pollution at workplaces and adult-onset asthma in the beginning of this millennium.

Authors:  Pål Graff; Mats Fredrikson; Pia Jönsson; Ulf Flodin
Journal:  Int Arch Occup Environ Health       Date:  2011-07-01       Impact factor: 3.015

6.  Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.

Authors:  A Johannessen; E R Omenaas; P S Bakke; A Gulsvik
Journal:  Thorax       Date:  2005-08-05       Impact factor: 9.139

7.  Computer based safety training: an investigation of methods.

Authors:  E S Wallen; K B Mulloy
Journal:  Occup Environ Med       Date:  2005-04       Impact factor: 4.402

8.  Occupation and the prevalence of respiratory health symptoms and conditions: the Atherosclerosis Risk in Communities Study.

Authors:  Maria C Mirabelli; Stephanie J London; Luenda E Charles; Lisa A Pompeii; Lynne E Wagenknecht
Journal:  J Occup Environ Med       Date:  2012-02       Impact factor: 2.162

9.  Feasible and simple exclusion criteria for pulmonary reference populations.

Authors:  Ane Johannessen; Ernst R Omenaas; Geir Egil Eide; Per S Bakke; Amund Gulsvik
Journal:  Thorax       Date:  2007-03-27       Impact factor: 9.139

Review 10.  Asthma caused by occupational exposures is common - a systematic analysis of estimates of the population-attributable fraction.

Authors:  Kjell Torén; Paul D Blanc
Journal:  BMC Pulm Med       Date:  2009-01-29       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.